By Eric Hamilton This article originally appeared on UW–Madison’s news page. University of Wisconsin–Madison researchers have developed nanoparticles that, in the lab, can activate immune responses to cancer cells. If they are shown to work as …
Homepage News Feature
3 most recent stories to be displayed on the SoP homepage.
School Strengthens Commitment to Diversity and Inclusion
Through new strategic plan initiatives and an added leadership position, the School is enhancing efforts to educate inclusive pharmacists.
Alumna Julie Dagam Honored as ASHP Fellow
Alumna Julie Dagam is honored as a 2019 American Society of Health-System Pharmacists fellow, in recognition of contributions to pharmacy practice and her profession.
Breaking the Opioid Cycle: Part 2
In the second in a three-part series exploring how School of Pharmacy researchers are curbing the opioid epidemic, faculty are testing a new tool to improve appropriate prescribing and leveraging pharmacist expertise to increase naloxone dispensing.
New PharmD Concentration Focuses on Rural Health Challenges
Through a new option in the School’s PharmD program, future pharmacists learn how to identify needs and innovate practice in areas that need it most.
Gavin Arteel Honored as 2019 PharmTox Alumnus of the Year
Alumnus Gavin Arteel is honored with 2019 PharmTox Alumnus of the Year for his distinguished contributions to liver disease research.
UW–Madison PharmD Students Outperform in 2019 Residency Match
A record number of PharmD students at the School of Pharmacy matched with ASHP residencies this year, making the School fourth in the nation for the most students matched with residencies.
UW–Madison School of Pharmacy Leads with One of the Best NAPLEX First-Time Pass Rates
PharmD students from the UW–Madison School of Pharmacy significantly outperformed their peers on the 2018 North American Pharmacist Licensure Exam (NAPLEX) with a first-time pass rate of 98.33 percent versus the national average for all accredited pharmacy schools of 89.46 percent.
UW–Madison School of Pharmacy’s Jennifer Golden Designs Promising New Compounds To Fight Deadly Mosquito-Transmitted Viruses
The School of Pharmacy makes a breakthrough in creating new small molecules that penetrate into the brain where the equine encephalitis viruses reside and interfere with viral replication to stop EEV. The research is funded by a new, five-year $21 million award from the National Institutes of Health (NIH).
The School’s Interprofessional Education Program Makes a Splash Nationwide
Associate Professor Joe Zorek co-authors national interprofessional education guidelines for health professions accreditors.